Formulations and methods of use for alpha connexin c-terminal (ACT) peptides
This invention relates to a topical gel drug product preparation containing a composition comprising an isolated polypeptide having a carboxy-terminal amino acid sequence of an alpha connexin (ACT peptide), peptide stabilizers, excipients, buffering agents, and the like. A formulation and preparation steps are disclosed for the manufacturing of a stable, elegant, and pourable topical gel. The resulting formulation possesses long term stability suitable for aesthetic as well as therapeutic applications including the prevention of scaring and accelerated healing of wounds. Methods for treatment of chronic wounds, including chronic ulcers, are also provided.
1. A composition for treating a chronic wound in a subject, consisting essentially of at least one alpha connexin polypeptide and a carrier, wherein the at least one alpha connexin polypeptide comprises the carboxy terminal-most 4 to 30 contiguous amino acids of an alpha connexin, or a conservative variant thereof, and wherein the carrier comprises hydroxyethylcellulose gel, wherein the hydroxyethylcellulose gel is present in the composition at a concentration of about 1.25% (w/w).
2. The composition of claim 1 , wherein the alpha connexin polypeptide comprises the amino acid sequence of SEQ ID NO: 9.
3. The composition of claim 1 , wherein the alpha connexin polypeptide comprises a cellular internalization transporter.
4. The composition of claim 3 , wherein the cellular internalization transporter is an antennapedia sequence.
5. A method of treating a chronic wound in a subject, comprising administering to a subject in need thereof the composition of claim 1 .